Related by context. All words. (Click for frequent words.) 81 BRCA1 69 BRCA mutations 69 BRCA mutation 67 BRCA1 gene 67 BRCA2 66 BRCA genes 63 BRCA2 mutations 63 BRCA gene 62 mutated BRCA1 61 BRCA1 mutations 61 BRCA2 gene 61 BRCA2 mutation 61 breast cancer genes BRCA1 60 BRCA1 mutation 59 genes BRCA1 58 BRCA2 gene mutation 57 hereditary breast cancer 57 BRCA gene mutation 57 breast cancer gene mutation 57 ApoE4 gene 56 APOE e4 56 breast cancers 56 APOE 56 gene mutation 55 PALB2 55 BRCA2 carriers 55 HNPCC 55 mutation 55 BRAC2 54 TACI mutations 54 ovarian cancer 54 BRCA1 gene mutation 54 gene BRCA2 54 mutated gene 54 gene mutations 54 HER2 54 MSH2 54 BRCA2 mutation carriers 54 ovarian cancers 53 BRCA gene mutations 53 ApoE4 53 aneuploidy 53 HPV 53 noncarriers 53 breast cancer 53 APOE gene 53 atypia 53 estrogen receptor negative 53 LQTS 53 CYP#C# * 53 BARD1 53 APOE4 53 V Leiden 53 prenatal diagnosis 53 atypical hyperplasia 53 genes BRCA 52 BRCA2 breast cancer 52 chromosomal abnormalities 52 BRCA2 gene mutations 52 KRAS mutations 52 KRAS mutation 52 PTPN# 52 BRCA mutation carriers 52 BRIP1 51 CHEK2 51 BRCA testing 51 invasive breast cancer 51 CDKN2A 51 VKORC1 51 apolipoprotein E 51 human leukocyte antigen 51 ApoE 51 genotype 51 apolipoprotein E gene 51 HIV 51 latent TB 51 prophylactic mastectomy 51 breast carcinomas 51 Ashkenazi Jewish 50 amniocentesis 50 germline mutations 50 abnormal mammogram 50 oophorectomy 50 estrogen receptor ER 50 lung adenocarcinoma 50 estrogen receptor 50 CYP#C# [001] 50 colorectal cancer CRC 50 haptoglobin 50 Tay Sachs 50 HTLV 50 ASCUS 50 endometrial cancers 50 HPV# 50 mutations 50 HLA B 50 colon cancers 50 colorectal cancer 50 ERCC1 50 gene variant 50 BRCA1 BRCA2 50 EGFR mutation 50 tamoxifen 50 G#S mutation 50 Breast Cancer Risk 50 TGFBR1 * 6A 50 mutated BRCA 50 IgA deficiency 50 MYH9 gene 50 endometrial cancer 50 EGFR gene 49 HLA B# 49 MTHFR gene 49 Tamoxifen 49 prostate specific 49 breast cancer gene mutations 49 thyroglobulin 49 MLH1 49 HBsAg 49 ApoE4 allele 49 variant allele 49 TP# mutation 49 genetic variant 49 genetic abnormality 49 TCF#L# 49 deleterious mutation 49 CaP 49 hereditary hemochromatosis 49 familial pancreatic cancer 49 HBV 49 HER2 gene 48 genetic abnormalities 48 ovarian tumors 48 CDK4 48 genetic mutations 48 BRCA1 mutation carriers 48 recessive mutations 48 contralateral breast cancer 48 homozygous 48 familial ALS 48 recurrent ovarian cancer 48 PCa 48 hereditary breast 48 inherited mutations 48 APOE genotype 48 BRAF gene 48 APOL1 48 Fragile X gene 48 Pap smear 48 Li Fraumeni 48 preventive mastectomies 48 chlamydial infection 48 Hybrid Capture 48 TCF#L# gene 48 TP# mutations 48 2 diabetes T2D 48 breast cancer recurrence 48 hormone therapy estrogen 48 NKX2 48 estrogen receptor positive 48 NF1 48 CIN2 48 allele 48 mutant gene 48 breast tumors 48 CYP#D# 48 KIF6 gene 48 gestational diabetes mellitus 48 HER2 negative 48 thalassemia trait 48 CETP VV 48 colorectal neoplasia 48 CDH1 48 haplotype 48 colorectal cancers 48 ERBB2 48 K ras mutations 48 herpes simplex virus 48 SNPs 48 Amniocentesis 47 BRAF V#E mutation 47 mutated K ras 47 gene variants 47 prediabetes 47 Genotype 47 BRCA carriers 47 microdeletions 47 preventive mastectomy 47 GSTP1 47 PTEN gene 47 seronegative 47 APOE e4 gene 47 HNSCC 47 Her2 47 homozygotes 47 PSA screening 47 Li Fraumeni syndrome 47 PTEN mutations 47 polymorphism 47 poor metabolizers 47 p# mutations 47 APOE ε4 47 antigen PSA 47 familial adenomatous polyposis 47 IDH2 47 EGFR 47 ε4 47 tumor recurrence 47 BRACAnalysis 47 chromosomal aberrations 47 anaplastic lymphoma kinase 47 abnormal cytology 47 proband 47 genotyped 47 ApoE gene 47 metastatic cancer 47 thrombophilia 47 Her2/neu 47 lobular carcinoma 47 faulty BRCA1 gene 47 SHBG 47 HER2 receptor 47 FLT3 47 KRAS gene 47 heterozygous 47 diabetes mellitus DM 47 testicular germ cell 47 apolipoprotein E4 46 salpingo oophorectomy 46 DCIS 46 CCR5 delta# 46 neuroblastoma tumors 46 cervical intraepithelial neoplasia 46 ADRB2 46 K ras gene 46 mosaicism 46 FGFR2 46 gestational diabetes 46 genetic variants 46 HCV genotype 46 PSA prostate 46 genetic disorders 46 faulty BRCA2 gene 46 Y STR 46 alleles 46 MTHFR 46 ADH1B * 46 PTEN mutation 46 IDH1 46 HPV infections 46 mtDNA mutations 46 CYP#C# [002] 46 PIK3CA 46 ABCB1 46 MLL2 46 deCODE BreastCancer TM 46 susceptibility gene 46 spontaneous preterm delivery 46 premature ovarian 46 CIN2 + 46 Fatty Liver Disease 46 GISTs 46 Hepatitis B virus 46 NNRTIs 46 autoantibodies 46 prostate cancers 46 AAT deficiency 46 MnSOD 46 breast ovarian 46 advanced adenomas 46 GBV C 46 breast cancer subtypes 46 peritoneal cancer 46 preeclampsia 46 Pap test 46 microsatellite instability 46 UGT#A# * 46 T#I [002] 46 polycystic ovary syndrome 46 sporadic ALS 46 thalassemia 46 KRAS wild 46 colon tumors 46 PSA velocity 46 neurofibromatosis type 46 1 diabetes T1D 46 breast cancer metastasis 46 rs# [002] 46 CYP#D# gene 46 #p# [001] 46 gene amplification 46 operable breast cancer 46 subclinical hyperthyroidism 46 WT1 46 uterine ovarian 46 specific antigen 46 5 HTTLPR 46 trisomy 46 penetrance 46 genetic mutation 46 PCA3 scores 46 breast carcinoma 46 Human Papillomavirus 46 HER2 overexpression 46 chromosomal defects 46 estrogen receptor progesterone receptor 46 diabetes 46 epithelial ovarian cancer 46 C#Y 46 defective gene 46 PGD 46 Epidermal Growth Factor Receptor 46 MSH6 46 APOE allele 45 herpes simplex 45 HER2 positive breast cancer 45 K#N 45 HPV types 45 APOE epsilon 4 45 CC genotype 45 #q#.# [001] 45 RhD 45 NRTIs 45 MC1R 45 premutation 45 mutated genes 45 ovaries removed 45 CCL#L# 45 #q# [002] 45 TOP2A 45 Breast Cancer Recurrence 45 grade cervical intraepithelial 45 micrometastases 45 haplotypes 45 variant alleles 45 Recurrence Score 45 PARP inhibition 45 Trisomy 45 Rh factor 45 EGFR mutations 45 Rh negative 45 JAK2 mutation 45 Gene Mutation 45 IKZF1 45 IGFBP 45 HER2/neu 45 von Willebrand disease 45 advanced adenoma 45 #q# [001] 45 lymph node biopsies 45 FMR1 gene 45 Haptoglobin 45 latent TB infection 45 breast cancer susceptibility genes 45 narcolepsy cataplexy 45 diabetes mellitus T2DM 45 NNRTI resistance 45 tumor suppressor gene 45 FMR1 45 HMGA2 45 Aneuploidy 45 HER-2/neu 45 DRD4 45 preimplantation genetic diagnosis 45 cyclin D1 45 Klinefelter syndrome 45 UGT#A# 45 folate supplementation 45 K#R [002] 45 Adjuvant chemotherapy 45 familial hypercholesterolemia 45 pancreatic cancers 45 lobular cancer 45 allele frequencies 45 EUS FNA 45 TMEM#B 45 distant metastases 45 Wwox 45 polycystic ovary syndrome PCOS 45 mitochondrial DNA 45 APOC3 45 prenatally diagnosed 45 statin medications 45 IDH1 mutation 45 abnormal cervical 45 KRAS oncogene 45 K RAS 45 genetic defects 45 Clusterin 45 premenopausal 45 nonmelanoma skin cancers 45 Janus kinase 45 IL#R 45 adenomatous polyps 45 PARP inhibitor 45 abnormal mammograms 45 fecal occult blood 45 HLA DR4 45 KIF6 gene variant 45 Zolinza 44 GIST tumors 44 micro RNAs 44 TOMM# 44 BRAF mutation 44 heritable genetic 44 pCR 44 HIV infection 44 repeat allele 44 TP# gene 44 letrozole 44 single nucleotide polymorphism 44 genomewide 44 hormone receptor positive 44 BRACAnalysis ® 44 K ras mutation 44 mtDNA 44 postmenopausal breast cancer 44 aneuploidy screening 44 HCV SPRINT 44 hormone receptor negative 44 Ovary removal 44 HbA1C 44 polymorphisms 44 Cervista HPV 44 CFTR gene 44 dysbindin 44 Cytogenetic 44 Gaucher disease 44 invasive prenatal 44 K ras 44 univariate analyzes 44 extracolonic findings 44 hormonal therapy 44 tamoxifen therapy 44 VIPR2 44 nucleoside analogues 44 Wiskott Aldrich syndrome 44 monozygotic twin 44 precancer 44 invasive carcinoma 44 chromosomal disorders 44 APOE4 gene 44 diabetes mellitus 44 prostate cancer CaP 44 CNVs 44 cardiac channelopathies 44 cystatin C 44 OPRM1 gene 44 dutasteride 44 serostatus 44 axillary node dissection 44 HPV infection 44 prostate biopsy 44 LRP5 44 Hepatitis C virus 44 Chromosome 44 GSTM1 gene 44 Metastases 44 gene variation 44 HFE gene 44 advanced neoplasia 44 hydroxyvitamin D levels 44 CGG repeats 44 prostate cancer 44 human herpesvirus 44 mammographic density 44 lipoprotein 44 vWD 44 imatinib resistance 44 elevated CRP 44 factor receptor 44 malignant lesions 44 estrogen therapy 44 metastatic colon cancer 44 colorectal screening 44 chromosomal defect 44 p# mutation 44 ALK mutations 44 TLR3 44 Breast Cancer 44 Prostate Specific Antigen 44 HLA DQ2 44 diagnosis PGD 44 hepatitis C genotype 44 Prostate Specific Antigen PSA 44 HGPIN 44 COX2 44 CIN3 + 44 LRAT 44 TT genotype 44 MCADD 44 Breast Cancers 44 PARP inhibitors 44 Invasive Breast Cancer 44 uterine cancers 44 HCV infection 44 H. pylori 44 HER2 expression 44 medulloblastoma 44 promoter hypermethylation 44 Gaucher Disease 44 Fragile X 44 HbF 44 medulloblastomas 44 HDL cholesterol 44 anastrozole 44 HCV 44 MYCN amplification 44 aromatase inhibitors 44 adjuvant radiation 44 EGFR inhibitors 44 Tay Sachs disease 44 HCV infected 43 metabolic syndrome 43 HBV infection 43 uterine rupture 43 LRRK2 gene 43 heterozygotes 43 Ashkenazi Jews 43 serous ovarian cancer 43 mutant allele 43 human immunodeficiency virus 43 DAT1 43 colon cancer 43 genes CYP#C# 43 prophylactic mastectomies 43 mutant alleles 43 faulty BRCA genes 43 gallstone disease 43 MetS 43 HLA 43 FTO gene 43 pancreatic adenocarcinoma 43 intestinal biopsy 43 CYP#D# genotype 43 MDM2 43 screening mammogram 43 Hepatitis B Virus 43 Hodgkin lymphoma HL 43 primary ovarian insufficiency 43 Squamous 43 Velculescu 43 HER2 positive cancers 43 genetic variants associated 43 screening colonoscopy 43 genes predisposing 43 BRAF mutations 43 rs# [004] 43 CMV 43 long QT syndrome 43 FXTAS 43 lymph node metastases 43 SORL1 43 X chromosome 43 somatic mutations 43 Rh positive 43 Mitochondrial DNA 43 herpesviruses 43 colorectal polyps 43 TRAF1 C5 43 missense mutations 43 abnormal Pap 43 pre menopausal 43 cervical lesions 43 invasive cervical cancer 43 HCV genotypes 43 KRAS 43 genetic 43 GPC5 43 SLNB 43 claudin 43 platelet reactivity 43 NAFLD 43 FCGR3A 43 genetic polymorphisms 43 abnormal Pap test 43 KCNE2 43 hepatitis B infection 43 Breast Cancer Treatment 43 celiac disease 43 systemic lupus erythematosus SLE 43 GNAQ 43 diffuse gastric 43 ovarian endometrial 43 MHC molecules 43 AAT Deficiency 43 promoter methylation 43 CIN3 43 medullary thyroid cancer 43 Ovarian cancer 43 SMN1 gene 43 ZNF# 43 grade cervical dysplasia 43 recurrent VTE 43 karyotype 43 genotypes 43 cancers 43 chromosomal rearrangement 43 fetuin 43 Cardiovascular Risk 43 NF1 gene 43 Aggressive Prostate Cancer 43 urothelial carcinoma 43 Prostate specific antigen 43 autosomal recessive 43 aneuploid 43 germline 43 STAT4 43 statins 43 low expressors 43 toxoplasmosis 43 ALCL 43 CNTNAP2 43 subclinical atherosclerosis 43 #p# [003] 43 Fanconi anemia 43 bladder cancers 43 intensive statin therapy 43 premature menopause 43 Polycystic Ovarian Syndrome PCOS 43 adenoma 43 Y chromosome 43 maternally inherited 43 latent tuberculosis infection 43 NY ESO 43 Cowden syndrome 43 prostate pancreatic 43 invasive ductal 43 menopausal hormone therapy 43 spontaneous mutations 43 lupus anticoagulant 43 activating mutations 43 MGUS 43 p# gene 43 chromosomal anomalies 43 dopamine D4 receptor 43 Acute Myelogenous Leukemia 43 JAK2 V#F 43 exemestane 43 baseline HbA1c 43 axillary dissection 43 recurrent miscarriages 43 prostate cancer PCa 43 sCJD 43 USPSTF 43 HER2 positive tumors 43 ependymoma 43 SE alleles 43 rs# [003] 43 renal carcinoma 43 pre eclampsia 43 activating mutation 43 CMV disease 43 anal cancers 43 autosomal 43 RBP4 43 testosterone supplementation 43 NMP# 43 adenomas 43 overexpress HER2 43 autoimmunity 43 HLA DQ 43 NFkB 43 atypical ductal hyperplasia 43 BRCA deficient 43 colorectal carcinoma 43 nonsmall cell lung cancer 43 T2DM 43 polycystic ovarian syndrome PCOS 42 SPINK1 42 linkage disequilibrium 42 major histocompatibility complex 42 Genital Herpes 42 Flexi Scope 42 frequently benign tumor 42 premenopausal breast cancer 42 gene APOE 42 unexplained infertility 42 genetic syndromes 42 NNRTI 42 neuroblastomas 42 metastatic disease 42 neuroblastoma 42 MODY 42 paternal lineage 42 subclinical hypothyroidism 42 virologic failure 42 mild gestational diabetes 42 PITX2 42 familial hypercholesterolaemia FH 42 G6PD deficiency 42 lobular involution 42 COMT gene 42 spontaneous preterm birth 42 hepatitis C virus 42 fasting glucose 42 immunohistochemistry 42 Glioma 42 germline mutation 42 undergone hysterectomy 42 NF2 42 venous blood clots 42 RhD negative 42 cytomegalovirus 42 adenocarcinomas 42 ErbB2 42 beta thalassemia 42 haematopoietic 42 FTO variant 42 HPV genotypes 42 Niemann Pick disease 42 contralateral breast 42 tumor suppressor 42 dizygotic twins 42 HER2 + 42 osteopenia 42 human leukocyte antigen HLA 42 CALHM1 42 JAK2 gene 42 epigenetic changes 42 risk HPV genotypes 42 allelic 42 galectin 3 42 seminoma 42 p# protein 42 NPM1 mutations 42 sentinel node biopsy 42 metastases 42 benign polyps 42 de novo mutations 42 axillary lymph nodes 42 basal cell nevus syndrome 42 colorectal cancer screening 42 yearly mammograms 42 DQB1 * 42 SMN1 42 FSGS 42 uterine cancer 42 adjuvant chemotherapy 42 R#W [002] 42 hormonal therapies 42 rs# [001] 42 endometrial carcinoma 42 monozygotic twins 42 smoldering myeloma 42 gene fusions 42 surgical biopsy 42 abnormal pap 42 taxane therapy 42 melanoma tumors 42 Haplogroup 42 sentinel lymph node biopsy 42 prognostic markers 42 lobular breast cancer 42 normal karyotype 42 homozygous FH 42 MEF2A 42 Polycystic ovary syndrome PCOS 42 venous thromboembolism 42 poorer prognosis 42 placental malaria 42 HLA genes 42 Kufs disease 42 prostate adenocarcinoma 42 antisense RNA 42 TTTS 42 lobular carcinomas 42 Anal cancer 42 Subtype 42 PALB2 gene 42 BCR ABL 42 breast biopsies 42 prostate specific antigen 42 malignancy 42 anovulatory infertility 42 Chronic Lymphocytic Leukemia 42 Chromosomal 42 Cushing syndrome 42 MicroRNA 42 insulin resistance syndrome 42 gynecologic cancer 42 abnormal Pap smears 42 recurrent miscarriage 42 hypermethylation 42 Breast Ovarian Cancer 42 endometrial 42 Cholangiocarcinoma 42 Acute myeloid leukemia 42 nestin 42 topo II 42 tumor suppressor genes 42 pleural mesothelioma 42 T2D 42 asymptomatic 42 T1DM 42 papillary RCC 42 prostate biopsies 42 colorectal adenomas 42 uPAR 42 breast caner 42 MSMB 42 Osteosarcoma 42 vertebral fracture 42 cervical carcinoma 42 tumor histology 42 nonmelanoma skin cancer 42 shorter telomeres 42 gastrointestinal stromal tumors 42 Colorectal Cancer 42 gynecologic cancers 42 bone marrow transplants 42 acute leukemias 42 JAK2 42 HLA molecules 42 CMV infection 42 ductal carcinomas 42 microalbuminuria 42 aneuploidies 42 precancerous cervical 42 HER2 positive 42 Heterozygous 42 SHANK3 42 invasive ductal breast cancer 42 Meckel Gruber 42 chromosome abnormality 42 invasive cervical cancers 42 Malignant Melanoma 42 tyrosine kinase inhibitors 42 overexpress 42 CAG repeats 42 monogenic diabetes 42 FGFR1 42 oropharyngeal cancer 42 QuantiFERON 42 metabolic syndrome MetS 42 glycogen synthase kinase 42 adjuvant radiotherapy 42 distant metastasis 42 Hemophilia B 42 cancerous polyps 42 G allele 42 precancers 42 STAT3 42 allelic variants 42 varicocele 42 causal variants 42 human papillomaviruses HPV 42 axillary nodes 42 fraternal twin pairs 42 cytology 42 breast MRIs 42 Hashimoto thyroiditis 42 BCL#A 42 breast endometrial 42 antiretroviral regimens 42 Prostate Cancer 42 adrenal function 42 myeloproliferative 42 liver metastasis 42 cytogenetic 42 onset Alzheimer disease 41 FSHD 41 pelvic lymphadenectomy 41 ADPKD 41 CT colonography 41 pathogenic mutations 41 HER2 amplification 41 PDGFRA 41 pre cancerous polyps 41 EGFR protein 41 microdeletion 41 lung tumors 41 monozygotic 41 BRAF V#E 41 Mutation 41 micro RNA 41 T1D 41 #q# deletion 41 ADAM# 41 seropositivity 41 FGFR3 41 testicular cancers 41 KRAS status 41 SNP rs# [001] 41 genetic markers 41 Genetic variants 41 ovarian uterine 41 human papillomavirus HPV 41 prognostic marker 41 Thyroid Cancer 41 genetic variations 41 sarcosine 41 estrogen progestin therapy 41 spontaneous mutation 41 Von Willebrand disease 41 dopamine transporter gene 41 Gene Mutations 41 cervical cancer 41 genotypic 41 pre implantation genetic 41 colorectal tumors 41 LRRK2 mutation 41 Human Papillomavirus HPV 41 malignant pleural mesothelioma 41 prenatal ultrasound 41 HOTAIR 41 Polymorphisms 41 Epstein Barr virus EBV 41 pertuzumab 41 thromboembolism 41 ALK gene 41 genomic alterations 41 genotypic resistance 41 SCN5A 41 ovarian carcinoma 41 XMRV 41 gefitinib 41 cell adhesion molecule 41 lung cancer 41 Cervista HPV HR 41 Metastatic Prostate Cancer 41 hormone deprivation 41 CCR5 tropic HIV 41 elevated LDL cholesterol 41 bowel cancer 41 microcephalin 41 sexually transmitted infection 41 rheumatoid factor 41 gliomas 41 herpes virus 41 progesterone receptor negative 41 intestinal polyps 41 probands 41 Uterine cancer 41 nodal metastases 41 chromosome #p#.# 41 Acute Myeloid Leukaemia AML 41 maternal lineage 41 Vpu 41 thrombospondin 41 pre eclamptic 41 genital herpes 41 HLA DR2 41 Polycystic Ovary Syndrome 41 Endometrial Cancer 41 MCAD deficiency 41 sentinel nodes 41 exome sequencing 41 SORL1 gene 41 progranulin gene 41 untreated celiac disease 41 ALDH2 41 HIV HCV coinfected 41 endostatin 41 oligodendrogliomas 41 deletion 5q 41 homozygosity 41 mitochondrial diseases 41 DICER1 gene 41 alternatively spliced 41 Prostate Cancer Risk 41 malignant transformation 41 gene 41 BMPR2 41 gefitinib Iressa 41 protein encoded 41 vaginal cancers 41 microRNA miR 41 PICALM 41 M. genitalium 41 lupus 41 psychiatric comorbidity 41 RAR beta 41 unexplained mental retardation 41 elevated triglyceride levels 41 meningioma 41 postoperative delirium 41 congenital adrenal hyperplasia CAH 41 stage IIIA 41 preimplantation genetic diagnosis PGD 41 postmenopausal 41 hereditary predisposition 41 microvascular disease 41 Adenomas 41 Src 41 Rb gene 41 Metabolic Syndrome 41 precancerous cervical lesions 41 Tay Sachs Disease 41 Neuregulin 1 41 Herpes Simplex Virus 41 retrovirus 41 colon polyps 41 basal cell carcinomas 41 dopamine receptor gene 41 palladin 41 Breast Tumors 41 colorectal carcinomas 41 GnRH agonists